Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

GYKI-47261 dihydrochloride

Copy Product Info
😃Good
Catalog No. T38601Cas No. 1217049-32-5
Alias GYKI47261 dihydrochloride

GYKI-47261 dihydrochloride is an orally active and selective AMPA receptor antagonist, also a CYP2E1 inducer with broad anticonvulsant and neuroprotective activity, used in neurological and cardiovascular research.

GYKI-47261 dihydrochloride

GYKI-47261 dihydrochloride

Copy Product Info
😃Good
Purity: 99.14%
Catalog No. T38601Alias GYKI47261 dihydrochlorideCas No. 1217049-32-5
GYKI-47261 dihydrochloride is an orally active and selective AMPA receptor antagonist, also a CYP2E1 inducer with broad anticonvulsant and neuroprotective activity, used in neurological and cardiovascular research.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$293In StockIn Stock
5 mg$718In StockIn Stock
10 mg$987-In Stock
25 mg$1,520-In Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.14%
Appearance:Solid
Color:White to Gray
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
GYKI-47261 dihydrochloride is an orally active and selective AMPA receptor antagonist, also a CYP2E1 inducer with broad anticonvulsant and neuroprotective activity, used in neurological and cardiovascular research.
Targets&IC50
AMPA:2.5 μM
In vitro
GYKI-47261 dihydrochloride inhibits AMPA or rhodosine-induced whole cell currents in isolated neurons. [1]
In vivo
GYKI-47261 dihydrochloride (200 mg/kg orally) is highly active in transient focal ischemia models.
Antiischemic effect of GYKI-47261 dihydrochloride (6 mg/kg iv) in rats with transient focal cerebral ischemia.
GYKI-47261 dihydrochloride effectively alleviates tremor induced by oxotremorine, a cholinergic agonist, in the treatment of Parkinson's disease. [1]
SynonymsGYKI47261 dihydrochloride
Chemical Properties
Molecular Weight395.71
FormulaC18H17Cl3N4
Cas No.1217049-32-5
SmilesClC1=CC(C(C2=CC=C(N)C=C2)=NN3C=C(C)N=C3C4)=C4C=C1.Cl.Cl
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy GYKI-47261 dihydrochloride | purchase GYKI-47261 dihydrochloride | GYKI-47261 dihydrochloride cost | order GYKI-47261 dihydrochloride | GYKI-47261 dihydrochloride chemical structure | GYKI-47261 dihydrochloride in vivo | GYKI-47261 dihydrochloride in vitro | GYKI-47261 dihydrochloride formula | GYKI-47261 dihydrochloride molecular weight